Free shipping on orders over $150 | All products third-party tested for 99%+ purity Shop Now
Military/VA Coverage for GLP-1 Weight Loss Medications
Learn about TRICARE and VA coverage for GLP-1 medications. Explore telehealth options and compounded alternatives for service members and veterans.
By Dr. Sarah Mitchell, MD, FACE|Reviewed by Dr. James Chen, PharmD|
In This Article
Key Takeaway
Learn about TRICARE and VA coverage for GLP-1 medications. Explore telehealth options and compounded alternatives for service members and veterans.
Medically reviewed by Dr. Sarah Mitchell, MD (Board-Certified Obesity Medicine, 12+ years clinical experience
If you're a service member, veteran, or military family member trying to get VA military GLP-1 coverage, you already know the system can be complicated. Between TRICARE formulary restrictions, VA pharmacy limitations, and long wait times, getting access to GLP-1 weight loss medications through military healthcare isn't always straightforward.
Key Takeaways:
- TRICARE Coverage for GLP-1 Medications
- VA Pharmacy and GLP-1 Access
- Telehealth Options for Service Members and Veterans
- Cost Comparison: TRICARE vs. VA vs. Telehealth
- Learn how to advocate for glp-1 access within military healthcare
But you have options. This guide breaks down what TRICARE and the VA currently cover, where the gaps are, and how telehealth platforms like FormBlends can help you get treatment without the bureaucratic delays.
TRICARE Coverage for GLP-1 Medications
TRICARE is the health insurance program for active duty service members, retirees, and their families. Its coverage of GLP-1 medications depends on which TRICARE plan you have and why the medication is being prescribed.
For type 2 diabetes: TRICARE generally covers GLP-1 receptor agonists when prescribed for blood sugar management. Semaglutide and tirzepatide have been approved by the FDA for type 2 diabetes, and TRICARE's formulary typically includes them for this indication. You may still need prior authorization, and your provider may need to document that other treatments were tried first.
For weight loss: This is where it gets trickier. TRICARE's coverage of GLP-1 medications specifically for weight management has been more limited. Coverage policies change frequently, and what's covered can depend on your specific plan tier and whether the medication has full formulary status for obesity treatment.
The TRICARE formulary is managed by the Department of Defense Pharmacy and Therapeutics Committee. They review medications regularly. The status of GLP-1 drugs for weight loss indication can shift from year to year. Check the current TRICARE formulary search tool for the most up-to-date information.
Even when a medication is on the formulary, copays vary by plan. TRICARE Prime, Select, and For Life all have different cost structures. Active duty members typically pay the least. Retirees and family members may face higher out-of-pocket costs.
VA Pharmacy and GLP-1 Access
"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.") Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital
The VA healthcare system has its own formulary, separate from TRICARE. The VA has been expanding access to GLP-1 medications, but availability can vary significantly by facility.
The VA National Formulary includes certain GLP-1 medications for diabetes management. For weight loss specifically, access has historically required additional authorization. Your VA provider needs to document medical necessity, and in many cases, you need to have tried other interventions first (such as the VA's MOVE! Weight Management Program.
Wait times can be a barrier. Some VA facilities have long wait lists for endocrinology or weight management clinics. If you're at a rural VA or one with limited specialty access, getting an appointment with a provider who can prescribe GLP-1 medications may take weeks or months.
Free Download: GLP-1 Eligibility Self-Assessment Checklist
Prepare for your provider visit) whether it's at the VA, through TRICARE, or via telehealth. This checklist covers BMI, qualifying conditions, and medication history so you walk in ready. Get yours free (we'll email it to you instantly.
[Download the Checklist]
The VA has been increasingly recognizing obesity as a serious health condition that merits pharmaceutical intervention. Policy changes continue to expand access. But if you've been waiting and need help now, you're not limited to VA-only options.
Telehealth Options for Service Members and Veterans
Here's what many service members and veterans don't realize: you can use telehealth platforms alongside your military healthcare. You're not locked into TRICARE or the VA as your only path to GLP-1 treatment.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Patient Perspective:"I was surprised I qualified) I didn't think of myself as 'obese enough' for medication. But my BMI was 32 with high blood pressure, and my provider explained that's exactly who these medications were designed for.", Nicole F., 42, FormBlends patient (name changed for privacy)
FormBlends offers telehealth consultations with licensed providers who can prescribe compounded GLP-1 medications. These are personalized medications prepared by licensed US-based 503A pharmacies. They contain the same active ingredient as brand-name options but are often available at a significantly lower cost.
Complete a telehealth consultation with a licensed FormBlends provider
If prescribed, your compounded medication ships directly to you (including APO/FPO addresses for deployed service members
Track your progress with the FormBlends app, which logs doses, weight, and side effects
This approach works especially well for:
- Deployed service members who can't easily access military medical facilities
- Guard and Reserve members whose TRICARE coverage may have gaps
- Veterans who are enrolled in VA care but face long wait times for specialty appointments
- Military families who want to start treatment without managing prior authorization delays
Using a telehealth platform doesn't affect your military healthcare benefits. You're simply using an additional resource to get the care you need on your timeline.
Cost Comparison: TRICARE vs. VA vs. Telehealth
Let's talk numbers. The cost of GLP-1 medications varies dramatically depending on how you access them.
Brand-name at full retail: Without insurance, brand-name GLP-1 medications can cost $800 to $1,500+ per month. That's not realistic for most people, military or civilian.
Through TRICARE: If covered, your copay might range from $0 (active duty at military pharmacies) to $14-$77 depending on your plan and pharmacy type. But again, coverage for the weight loss indication isn't guaranteed.
Through the VA: If your VA provider prescribes it and the medication is on the VA formulary for your indication, the copay is typically $5-$11 for a 30-day supply. The challenge is getting the prescription in the first place.
Through FormBlends: Compounded GLP-1 medications through FormBlends are priced transparently. Check our pricing page for current rates. Many service members find this option more affordable than brand-name retail and faster than working through military healthcare bureaucracy.
Some military members use a combined approach. They work with their VA or TRICARE provider for primary care while using telehealth for GLP-1 access. This isn't an either-or decision. It's about getting the care you need without unnecessary delays.
If you're exploring all your options, our guide on the most affordable GLP-1 options covers the market of pricing and access.
How to Advocate for GLP-1 Access Within Military Healthcare
If you want to pursue GLP-1 coverage through TRICARE or the VA, here's how to make the strongest case:
Document everything. Track your BMI, weight-related health conditions, and previous weight loss attempts. The more documentation you bring, the easier it is for your provider to justify medical necessity.
Ask about the weight management program first. Both TRICARE and the VA may require participation in a structured weight management program before approving GLP-1 medications. Enrolling in MOVE! or a similar program shows good faith and may accelerate your path to pharmaceutical treatment.
Request a referral to endocrinology. If your primary care provider is hesitant, ask for a referral to an endocrinologist or obesity medicine specialist. These specialists are more familiar with GLP-1 prescribing and may be more willing to advocate for coverage.
File an appeal if denied. Both TRICARE and the VA have appeal processes. If your request is denied, don't give up. Ask for the specific reason for denial, address it, and resubmit. Many initial denials are overturned on appeal.
Know your rights. As a service member or veteran, you've earned your healthcare benefits. Obesity is a recognized medical condition, not a lifestyle choice. Advocating for appropriate treatment is your right.
Frequently Asked Questions
Does TRICARE cover compounded GLP-1 medications?
TRICARE generally covers medications from its formulary and does not typically cover compounded medications. However, you can purchase compounded GLP-1 medications out of pocket through a telehealth provider like FormBlends. Many service members choose this route for faster access and transparent pricing.
Can I get GLP-1 medications through the VA if I'm not obese but have diabetes?
Yes. The VA is more likely to cover GLP-1 medications for type 2 diabetes management, as this is an FDA-approved indication. If you have type 2 diabetes and your provider determines a GLP-1 medication is clinically appropriate, coverage through the VA is generally more straightforward than for weight loss alone.
Will using a telehealth platform affect my military career or security clearance?
No. Seeking medical treatment through a telehealth platform is a personal healthcare decision. It is not reported to your chain of command and does not appear on security clearance reviews. Your health information is protected by HIPAA regardless of where you receive care.
Can FormBlends ship medications to APO/FPO military addresses?
Yes. FormBlends works with pharmacies that can ship to APO/FPO addresses. Shipping times may vary for overseas military addresses. Contact the FormBlends support team for specific shipping details to your location.
What if I'm transitioning out of the military) will I lose GLP-1 access?
Transitioning service members often experience gaps in healthcare coverage. If you're on a GLP-1 medication through military healthcare, consider establishing care with a telehealth provider like FormBlends before your TRICARE benefits end. This ensures continuity of treatment during your transition to civilian healthcare.
Start your experience Today
Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you, consultations are free and confidential.
Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3 (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4 (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
This content is provided for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.
Last updated: 2026-03-24
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are reviewed by licensed physicians but are not a substitute for a personal medical consultation.
Written by Dr. Sarah Mitchell, MD, FACE
Board-certified endocrinologist specializing in metabolic medicine and GLP-1 therapeutics. Reviewed by Dr. James Chen, PharmD, BCPS, clinical pharmacologist with expertise in compounded medications and peptide therapy.
Ready to get started?
Physician-supervised GLP-1 and peptide therapy, delivered to your door.